Skip to main content

Table 2 Distribution of metabolic components in study population

From: Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal

Metabolic components Control NAFLD X2 OR (95%CI)
Age: > 50 years 10% 16.4% 1.28 0.56(0.21–1.53)
BMI: ≥25 kg/m2 30% 57.5% 10.99 3.16(1.58–6.31)a
WC: > 94 cm (M),> 80 cm (F) 11.4% 56.1% 31.75 0.10(0.04–0.24)a
WC: > 102 cm (M),88 cm (F) 1.4% 30.1% 21.821 29.76(3.88–228.03)a
Blood Pressure: ≥130/85 mmHg 35.7% 56.1% 6.01 2.30(1.17–4.50)
TG: ≥150 mg/dl 2.9% 60.27% 53.98 51.58(11.71–227.12)a
Low HDL: < 40 mg/dl(M),< 50 mg/dl (F) 47.1% 69.8% 7.61 2.59(1.30–5.16)b
MetS + (NCEP ATPIII-criteria) 1.4% 13.6% 10.31 2.15(1.70–2.52)b
MetS + (IDF-criteria) 1.4% 30.1% 21.82 29.75(3.888–228.03)a
  1. a-p < 0.001, b-p < 0.005
  2. F female, M male, MetS + (NCEPATPIII) metabolic syndrome present by National Cholesterol Education Program Adult Treatment Panel III, MetS + (IDF) metabolic syndrome present by International Diabetic Federation